Mckesson lifts annual profit forecast on robust demand for specialty drugs
1. McKesson raised its annual profit forecast, exceeding Wall Street estimates. 2. The company attributed this to strong demand for specialty medicines.
1. McKesson raised its annual profit forecast, exceeding Wall Street estimates. 2. The company attributed this to strong demand for specialty medicines.
McKesson's raised profit forecast shows strong growth potential, similar to past earnings surprises that drove the stock up.
The raised profit forecast is likely to enhance investor confidence and push MCK's stock prices higher.
The immediate financial results and forecasts impact short-term investor sentiment and stock performance.